The Form 144 signals an insider's intent to sell a modest position, likely for personal liquidity. Monitor for the actual sale on Form 4, which would confirm execution. Given the small relative size, no material price impact is expected, but watch for any pattern of insider selling ahead of upcoming catalysts or earnings.
Price Chart
Executive Summary
Jeffrey A. Rona, an affiliated stockholder of Ovid Therapeutics, filed a Form 144 notice of intent to sell up to 150,000 shares of common stock through Morgan Stanley. The shares are held in a brokerage account and were acquired via ESPP purchases, restricted stock unit vestings, and a same-day stock option exercise for 85,025 shares. At OVID's current market cap of ~$523M, this represents a modest ~0.3% of shares outstanding, but the filing signals a planned monetization by an insider.
Key Facts
- Jeffrey A. Rona filed Form 144 to sell up to 150,000 shares of Ovid Therapeutics common stock.
- The shares are held at Morgan Stanley and were acquired through ESPP purchases, RSU vestings, and a stock option exercise on 08/14/2026.
- The filing includes a same-day exercise of 85,025 stock options for cash, which are part of the proposed sale.
- The total shares beneficially owned after the sale would be 195,297,857 (likely a placeholder or total outstanding, not Rona's holdings).
- The sale is planned for the open market via Nasdaq.
Financial Impact
Up to 150,000 shares sold; at current market cap of ~$523M, this is approximately 0.3% of outstanding shares. Dollar value not disclosed.
Risk Factors
- Insider selling may signal lack of confidence if followed by additional filings; however, this is a single, modest filing.
- The sale may not occur; Form 144 is an intent notice, not a completed transaction.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001311404-26-000005 |
| Document: 0001311404-26-000005-index.html | 0001311404-26-000005 |
| Document: 0001311404-26-000005.txt | 0001311404-26-000005 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 10w ago | 144 | $2.89 | awaiting T+60 | — | $2.23 (−22.84%) |
Jul 8, 2026 15w ago | 8-K | $2.73 $2.49 | ▼ −8.79% | ▼ −11.10% | $2.23 (−18.32%) |
Jun 3, 2026 20w ago | 8-K | $2.39 $2.93 | ▲ +22.59% | ▲ +20.10% | $2.23 (−6.69%) |
May 12, 2026 24w ago | Press Release | $2.87 $2.65 | ▼ −7.67% | ▼ −12.05% | $2.23 (−22.30%) |
Apr 27, 2026 26w ago | EFFECT | $2.69 $2.38 | ▼ −11.52% | ▼ −16.30% | $2.23 (−17.10%) |
Apr 21, 2026 26w ago | S-3 | $2.66 $2.44 | ▼ −8.27% | ▼ −13.05% | $2.23 (−16.17%) |
Apr 20, 2026 27w ago | 8-K | $2.89 $2.49 | ▼ −13.84% | ▼ −20.62% | $2.23 (−22.84%) |
Mar 18, 2026 31w ago | 8-K | $2.30 $2.21 | ▼ −3.91% | ▼ −15.44% | $2.23 (−3.04%) |
Mar 18, 2026 31w ago | Press Release | $2.30 $2.21 | ▼ −3.91% | ▼ −15.44% | $2.23 (−3.04%) |
Mar 18, 2026 31w ago | Press Release | $2.30 $2.21 | ▼ −3.91% | ▼ −15.44% | $2.23 (−3.04%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers